Lima-Gómez Virgilio, Blanco-Hernández Dulce Milagros Razo
Hospital Juárez de México, México, DF, Mexico.
Cir Cir. 2012 Jan-Feb;80(1):25-30.
Optical coherence tomography (OCT) quantifies changes of foveal thickness and macular volume after photocoagulation in diabetic macular edema. Macular volume evaluates the whole macula, but it may underestimate changes in foveal thickness induced by photocoagulation. We undertook this study to evaluate the concordance between macular volume and foveal thickness for identifying clinically significant changes of retinal thickness after photocoagulation for diabetic macular edema.
We carried out an observational, retrospective, longitudinal, analytical study. Center point thickness (CPT), central subfield mean thickness (CSMT) and macular volume were measured with OCT before photocoagulation and 3 weeks after in diabetic patients with focal macular edema (January 2006--January 2010). Concordance among variables to detect clinically significant changes (CPT >17%, CSMT >11%, macular volume >3%) was identified using the kappa test.
Sixty eight eyes were included; 47 eyes had nonproliferative retinopathy (69.1%). CPT increased significantly in 14.7% of the sample; CSMT in 8.8%, and macular volume in 11.8%. CPT decreased significantly in 4.4%, CSMT in 8.8%, and macular volume in 42.6%. Concordance was regular for CPT and CSMT increased (57%). Concordance was good for CPT and CSMT decreased (64%). Concordance was regular for CSMT and macular volume decreased in eyes with center involvement (43%). The remaining concordances were poor.
Two independent events happen after focal photocoagulation: involution of the original thickening and increase in CPT. In order to detect both events, evaluation of either foveal thickness alone or macular volume alone is insufficient.
Identifying the efficacy and safety of treatments for diabetic macular edema requires simultaneous measurement of CPT and macular volume.
光学相干断层扫描(OCT)可量化糖尿病性黄斑水肿光凝治疗后黄斑中心凹厚度和黄斑体积的变化。黄斑体积评估的是整个黄斑,但可能会低估光凝引起的黄斑中心凹厚度变化。我们开展本研究以评估黄斑体积与黄斑中心凹厚度之间的一致性,用于识别糖尿病性黄斑水肿光凝治疗后视网膜厚度的临床显著变化。
我们进行了一项观察性、回顾性、纵向分析研究。对2006年1月至2010年1月患有局灶性黄斑水肿的糖尿病患者在光凝治疗前及治疗后3周使用OCT测量中心点厚度(CPT)、中心子野平均厚度(CSMT)和黄斑体积。使用kappa检验确定变量之间检测临床显著变化(CPT>17%,CSMT>11%,黄斑体积>3%)的一致性。
纳入68只眼;47只眼患有非增殖性视网膜病变(69.1%)。样本中14.7%的CPT显著增加;8.8%的CSMT显著增加,11.8%的黄斑体积显著增加。4.4%的CPT显著降低,8.8%的CSMT显著降低,42.6%的黄斑体积显著降低。CPT和CSMT增加时一致性一般(57%)。CPT和CSMT降低时一致性良好(64%)。在有中心受累的眼中,CSMT和黄斑体积降低时一致性一般(43%)。其余的一致性较差。
局灶性光凝治疗后发生两个独立事件:原增厚的消退和CPT增加。为了检测这两个事件,单独评估黄斑中心凹厚度或黄斑体积是不够的。
确定糖尿病性黄斑水肿治疗的疗效和安全性需要同时测量CPT和黄斑体积。